TORONTO, ON – August 15, 2015 – Betty Cory, RAC and Lori Steinhoff – de Munnik, RAC, announced today that they have completed the management acquisition of Regxia Inc., a leading regulatory pharmaceutical and biotechnology consulting company situated in Toronto, Ontario providing full lifecycle regulatory expertise for Health Canada, US Food and Drug Administration and the European Medicines Agency to their clients.
Since co-founding Regxia in 2007, Mrs. Cory (President) and Mrs. de Munnik (Vice President) have built the company to be one of the premier Canadian regulatory consulting firms. Under their leadership and direction Regxia Inc. has earned a reputation of being collaborative, delivering high quality and customized solutions consistent with their client’s company culture and the ever evolving regulatory environment. The desire to provide the client with a one-to-one experience allows Regxia to work seamlessly with their clients as a trusted partner.
By acquiring full control, Mrs. Cory and Mrs. de Munnik have strengthened their commitment to Regxia’s mission, core values and most importantly to their clients. With full control over the strategic direction of Regxia, Mrs. Cory and Mrs. de Munnik plan to continue leading the company towards increased growth, project quality, client satisfaction and client security.
“We are very excited to hold the reigns and drive our own future. The talent that is Regxia is unsurpassed in the industry and their dedication to the company’s mission and values is what has defined Regxia’s success. Our customers continue to comment on the level of service they receive and the professionalism of our staff. We have entered a very exciting time for the company and I am looking forward to the growth and success that is before us.” Betty Cory – President, Regxia Inc.
About Regxia Inc.
Regxia Inc. is a unique scientific and regulatory consulting firm serving the pharmaceutical and biotech industries. Regxia focuses on fostering long-term client relationships based on trust, reliability and common values. Regxia offers a full range of Regulatory Services to support client products at all stages of development, from concept to launch and through its lifecycle. Regxia has direct experience with pharmaceuticals, biologics, and medical devices in all therapeutic areas. The in-depth awareness and understanding of global regulatory requirements and regulatory strategy that Regxia’s staff possess allows them to minimize the time to market for their clients. Learn more at www.regxia.com
Contact: Cameron McGregor, Manager Business Development – email@example.com